1. Home
  2. CABA vs HWBK Comparison

CABA vs HWBK Comparison

Compare CABA & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.21

Market Cap

210.8M

Sector

Health Care

ML Signal

HOLD

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$34.35

Market Cap

231.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
HWBK
Founded
2017
1865
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
210.8M
231.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CABA
HWBK
Price
$2.21
$34.35
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$14.57
N/A
AVG Volume (30 Days)
1.8M
11.8K
Earning Date
11-10-2025
01-21-2026
Dividend Yield
N/A
2.36%
EPS Growth
N/A
259.86
EPS
N/A
3.19
Revenue
N/A
$77,904,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.61
Revenue Growth
N/A
45.83
52 Week Low
$0.99
$25.21
52 Week High
$3.67
$36.49

Technical Indicators

Market Signals
Indicator
CABA
HWBK
Relative Strength Index (RSI) 43.93 53.92
Support Level $2.12 $32.03
Resistance Level $2.49 $35.68
Average True Range (ATR) 0.12 1.16
MACD -0.02 -0.19
Stochastic Oscillator 28.21 54.98

Price Performance

Historical Comparison
CABA
HWBK

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.

Share on Social Networks: